| Aetna | Chemical Aversive Conditioning for Alcoholism | 2025-12-22 |
| Aetna | Mepolizumab (Nucala) | 2025-12-22 |
| Aetna | Secukinumab (Cosentyx) | 2025-12-22 |
| Aetna | Ostomy Supplies | 2025-12-22 |
| Aetna | Reslizumab (Cinqair) | 2025-12-22 |
| BCBS Premera WA AK Clinical | Total Artificial Hearts and Implantable Ventricular Assist | 2025-12-22 |
| BCBS Premera WA AK Clinical | Microwave Tumor Ablation | 2025-12-22 |
| BCBS Premera WA AK Clinical | Dynamic Spinal Visualization and Vertebral Motion | 2025-12-22 |
| BCBS Premera WA AK Clinical | 5.01.545 Pharmacologic Treatment of Benign Prostatic Hyperplasia | 2025-12-22 |
| BCBS Premera WA AK Clinical | 5.01.598 Pharmacologic Treatment to Reduce Serum Phosphorus | 2025-12-22 |